Skip to main content
Top
Published in: BMC Immunology 1/2017

Open Access 01-12-2017 | Research article

Functional expression of CCL8 and its interaction with chemokine receptor CCR3

Authors: Baosheng Ge, Jiqiang Li, Zhijin Wei, Tingting Sun, Yanzhuo Song, Naseer Ullah Khan

Published in: BMC Immunology | Issue 1/2017

Login to get access

Abstract

Background

Chemokines and their cognate receptors play important role in the control of leukocyte chemotaxis, HIV entry and other inflammatory diseases. Developing an effcient method to investigate the functional expression of chemokines and its interactions with specific receptors will be helpful to asses the structural and functional characteristics as well as the design of new approach to therapeutic intervention.

Results

By making systematic optimization study of expression conditions, soluble and functional production of chemokine C-C motif ligand 8 (CCL8) in Escherichia coli (E. coli) has been achieved with approx. 1.5 mg protein/l culture. Quartz crystal microbalance (QCM) analysis exhibited that the purified CCL8 could bind with C-C chemokine receptor type 3 (CCR3) with dissociation equilibrium constant (K D) as 1.2 × 10−7 M in vitro. Obvious internalization of CCR3 in vivo could be detected in 1 h when exposed to 100 nM of CCL8. Compared with chemokine C-C motif ligand 11 (CCL11) and chemokine C-C motif ligand 24 (CCL24), a weaker chemotactic effect of CCR3 expressing cells was observed when induced by CCL8 with same concentration.

Conclusion

This study delivers a simple and applicable way to produce functional chemokines in E. coli. The results clearly confirms that CCL8 can interact with chemokine receptor CCR3, therefore, it is promising area to develop drugs for the treatment of related diseases.
Appendix
Available only for authorised users
Literature
1.
go back to reference Van Coillie E, Van Damme J, Opdenakker G. The MCP/eotaxin subfamily of CC chemokines. Cytokine Growth Factor Rev. 1999;10(1):61–86.CrossRefPubMed Van Coillie E, Van Damme J, Opdenakker G. The MCP/eotaxin subfamily of CC chemokines. Cytokine Growth Factor Rev. 1999;10(1):61–86.CrossRefPubMed
2.
go back to reference Martine J, SAL S, Leurs R. Fundamentals of chemokines and Chemokine receptors. Weinheim: Wiley; 2011. Martine J, SAL S, Leurs R. Fundamentals of chemokines and Chemokine receptors. Weinheim: Wiley; 2011.
3.
go back to reference Rodriguez-Frade JM, Martinez AC, Mellado M. Chemokine signaling defines novel targets for therapeutic intervention. Mini Rev Med Chem. 2005;5(9):781–9.CrossRefPubMed Rodriguez-Frade JM, Martinez AC, Mellado M. Chemokine signaling defines novel targets for therapeutic intervention. Mini Rev Med Chem. 2005;5(9):781–9.CrossRefPubMed
4.
go back to reference Salanga CL, Handel TM. Chemokine oligomerization and interactions with receptors and glycosaminoglycans: the role of structural dynamics in function. Exp Cell Res. 2011;317(5):590–601.CrossRefPubMedPubMedCentral Salanga CL, Handel TM. Chemokine oligomerization and interactions with receptors and glycosaminoglycans: the role of structural dynamics in function. Exp Cell Res. 2011;317(5):590–601.CrossRefPubMedPubMedCentral
5.
6.
go back to reference Elsner J, Escher SE, Forssmann U. Chemokine receptor antagonists: a novel therapeutic approach in allergic diseases. Allergy. 2004;59(12):1243–58.CrossRefPubMed Elsner J, Escher SE, Forssmann U. Chemokine receptor antagonists: a novel therapeutic approach in allergic diseases. Allergy. 2004;59(12):1243–58.CrossRefPubMed
7.
go back to reference Proost P, Wuyts A, Conings R, Lenaerts JP, Put W, Van Damme J. Purification and identification of natural chemokines. Methods. 1996;10(1):82–92.CrossRefPubMed Proost P, Wuyts A, Conings R, Lenaerts JP, Put W, Van Damme J. Purification and identification of natural chemokines. Methods. 1996;10(1):82–92.CrossRefPubMed
8.
go back to reference Edgerton MD, Gerlach LO, Boesen TP, Allet B. Expression of chemokines in Escherichia Coli. Methods Mol Biol. 2000;138:33–40.PubMed Edgerton MD, Gerlach LO, Boesen TP, Allet B. Expression of chemokines in Escherichia Coli. Methods Mol Biol. 2000;138:33–40.PubMed
9.
go back to reference Wang M, Ge B, Li R, Wang X, Lao J, Huang F. Milligram production and biological activity characterization of the human chemokine receptor CCR3. PLoS One. 2013;8(6):e65500.CrossRefPubMedPubMedCentral Wang M, Ge B, Li R, Wang X, Lao J, Huang F. Milligram production and biological activity characterization of the human chemokine receptor CCR3. PLoS One. 2013;8(6):e65500.CrossRefPubMedPubMedCentral
10.
go back to reference Daugherty BL, Siciliano SJ, DeMartino JA, Malkowitz L, Sirotina A, Springer MS. Cloning, expression, and characterization of the human eosinophil eotaxin receptor. J Exp Med. 1996;183(5):2349–54.CrossRefPubMed Daugherty BL, Siciliano SJ, DeMartino JA, Malkowitz L, Sirotina A, Springer MS. Cloning, expression, and characterization of the human eosinophil eotaxin receptor. J Exp Med. 1996;183(5):2349–54.CrossRefPubMed
11.
go back to reference Struyf S, Menten P, Lenaerts JP, Put W, D'Haese A, De Clercq E, Schols D, Proost P, Van Damme J. Diverging binding capacities of natural LD78beta isoforms of macrophage inflammatory protein-1alpha to the CC chemokine receptors 1, 3 and 5 affect their anti-HIV-1 activity and chemotactic potencies for neutrophils and eosinophils. Eur J Immunol. 2001;31(7):2170–8.CrossRefPubMed Struyf S, Menten P, Lenaerts JP, Put W, D'Haese A, De Clercq E, Schols D, Proost P, Van Damme J. Diverging binding capacities of natural LD78beta isoforms of macrophage inflammatory protein-1alpha to the CC chemokine receptors 1, 3 and 5 affect their anti-HIV-1 activity and chemotactic potencies for neutrophils and eosinophils. Eur J Immunol. 2001;31(7):2170–8.CrossRefPubMed
14.
go back to reference Blaszczyk J, Coillie EV, Proost P, Damme JV, Opdenakker G, Bujacz GD, Wang JM, Ji X. Complete crystal structure of monocyte chemotactic protein-2, a CC chemokine that interacts with multiple receptors. Biochemistry. 2000;39(46):14075–81.CrossRefPubMed Blaszczyk J, Coillie EV, Proost P, Damme JV, Opdenakker G, Bujacz GD, Wang JM, Ji X. Complete crystal structure of monocyte chemotactic protein-2, a CC chemokine that interacts with multiple receptors. Biochemistry. 2000;39(46):14075–81.CrossRefPubMed
15.
go back to reference Lisboa LF, Egli A, Fairbanks J, O'Shea D, Manuel O, Husain S, Kumar D, Humar A. CCL8 and the immune control of cytomegalovirus in organ transplant recipients. Am J Transplant. 2015;15(7):1882–92.CrossRefPubMed Lisboa LF, Egli A, Fairbanks J, O'Shea D, Manuel O, Husain S, Kumar D, Humar A. CCL8 and the immune control of cytomegalovirus in organ transplant recipients. Am J Transplant. 2015;15(7):1882–92.CrossRefPubMed
16.
go back to reference Hori T, Naishiro Y, Sohma H, Suzuki N, Hatakeyama N, Yamamoto M, Sonoda T, Mizue Y, Imai K, Tsutsumi H, et al. CCL8 is a potential molecular candidate for the diagnosis of graft-versus-host disease. Blood. 2008;111(8):4403–12.CrossRefPubMedPubMedCentral Hori T, Naishiro Y, Sohma H, Suzuki N, Hatakeyama N, Yamamoto M, Sonoda T, Mizue Y, Imai K, Tsutsumi H, et al. CCL8 is a potential molecular candidate for the diagnosis of graft-versus-host disease. Blood. 2008;111(8):4403–12.CrossRefPubMedPubMedCentral
17.
go back to reference Rom S, Rom I, Passiatore G, Pacifici M, Radhakrishnan S, Del Valle L, Pina-Oviedo S, Khalili K, Eletto D, Peruzzi F. CCL8/MCP-2 is a target for mir-146a in HIV-1-infected human microglial cells. FASEB J. 2010;24(7):2292–300.CrossRefPubMedPubMedCentral Rom S, Rom I, Passiatore G, Pacifici M, Radhakrishnan S, Del Valle L, Pina-Oviedo S, Khalili K, Eletto D, Peruzzi F. CCL8/MCP-2 is a target for mir-146a in HIV-1-infected human microglial cells. FASEB J. 2010;24(7):2292–300.CrossRefPubMedPubMedCentral
18.
go back to reference Veldkamp CT, Koplinski CA, Jensen DR, Peterson FC, Smits KM, Smith BL, Johnson SK, Lettieri C, Buchholz WG, Solheim JC, et al. Production of recombinant chemokines and validation of refolding. Methods Enzymol. 2016;570:539–65.CrossRefPubMed Veldkamp CT, Koplinski CA, Jensen DR, Peterson FC, Smits KM, Smith BL, Johnson SK, Lettieri C, Buchholz WG, Solheim JC, et al. Production of recombinant chemokines and validation of refolding. Methods Enzymol. 2016;570:539–65.CrossRefPubMed
19.
go back to reference Cho HJ, Lee Y, Chang RS, Hahm MS, Kim MK, Kim YB, YK O. Maltose binding protein facilitates high-level expression and functional purification of the chemokines RANTES and SDF-1alpha from Escherichia Coli. Protein Expr Purif. 2008;60(1):37–45.CrossRefPubMed Cho HJ, Lee Y, Chang RS, Hahm MS, Kim MK, Kim YB, YK O. Maltose binding protein facilitates high-level expression and functional purification of the chemokines RANTES and SDF-1alpha from Escherichia Coli. Protein Expr Purif. 2008;60(1):37–45.CrossRefPubMed
20.
go back to reference Gustavsson M, Zheng Y, Handel TM. Production of Chemokine/Chemokine receptor complexes for structural biophysical studies. Methods Enzymol. 2016;570:233–60.CrossRefPubMed Gustavsson M, Zheng Y, Handel TM. Production of Chemokine/Chemokine receptor complexes for structural biophysical studies. Methods Enzymol. 2016;570:233–60.CrossRefPubMed
21.
go back to reference TT V, Koo BK, Song JA, Chong SH, Park CR, Nguyen MT, Jeong B, Ryu HB, Seong JY, Jang YJ, et al. Soluble overexpression and purification of bioactive human CCL2 in E. Coli by maltose-binding protein. Mol Biol Rep. 2015;42(3):651–63.CrossRef TT V, Koo BK, Song JA, Chong SH, Park CR, Nguyen MT, Jeong B, Ryu HB, Seong JY, Jang YJ, et al. Soluble overexpression and purification of bioactive human CCL2 in E. Coli by maltose-binding protein. Mol Biol Rep. 2015;42(3):651–63.CrossRef
22.
go back to reference Wang MQ, Ge BS, Yang QX, Jiang XY, Huang F. High-level production of biologically active chemokines in Escherichia Coli. Process Biochem. 2014;49(4):706–14.CrossRef Wang MQ, Ge BS, Yang QX, Jiang XY, Huang F. High-level production of biologically active chemokines in Escherichia Coli. Process Biochem. 2014;49(4):706–14.CrossRef
23.
go back to reference Heinemann A, Hartnell A, Stubbs VEL, Murakami K, Soler D, LaRosa G, Askenase PW, Williams TJ, Sabroe I. Basophil responses to chemokines are regulated by both sequential and cooperative receptor signaling. J Immunol. 2000;165(12):7224–33.CrossRefPubMed Heinemann A, Hartnell A, Stubbs VEL, Murakami K, Soler D, LaRosa G, Askenase PW, Williams TJ, Sabroe I. Basophil responses to chemokines are regulated by both sequential and cooperative receptor signaling. J Immunol. 2000;165(12):7224–33.CrossRefPubMed
24.
go back to reference Gong X, Gong W, Kuhns DB, Ben-Baruch A, Howard OM, Wang JM. Monocyte chemotactic protein-2 (MCP-2) uses CCR1 and CCR2B as its functional receptors. J Biol Chem. 1997;272(18):11682–5.CrossRefPubMed Gong X, Gong W, Kuhns DB, Ben-Baruch A, Howard OM, Wang JM. Monocyte chemotactic protein-2 (MCP-2) uses CCR1 and CCR2B as its functional receptors. J Biol Chem. 1997;272(18):11682–5.CrossRefPubMed
25.
go back to reference Zimmermann N, Conkright JJ, Rothenberg ME. CC chemokine receptor-3 undergoes prolonged ligand-induced internalization. J Biol Chem. 1999;274(18):12611–8.CrossRefPubMed Zimmermann N, Conkright JJ, Rothenberg ME. CC chemokine receptor-3 undergoes prolonged ligand-induced internalization. J Biol Chem. 1999;274(18):12611–8.CrossRefPubMed
26.
go back to reference Legler DF, Thelen M. Chemokines: chemistry, biochemistry and biological function. Chimia (Aarau). 2016;70(12):856–9.CrossRef Legler DF, Thelen M. Chemokines: chemistry, biochemistry and biological function. Chimia (Aarau). 2016;70(12):856–9.CrossRef
27.
go back to reference Tomczak A, Singh K, Gittis AG, Lee J, Garboczi DN, Murphy PM. Biochemical and biophysical characterization of cytokine-like protein 1 (CYTL1). Cytokine. 2017;96:238–46.CrossRefPubMed Tomczak A, Singh K, Gittis AG, Lee J, Garboczi DN, Murphy PM. Biochemical and biophysical characterization of cytokine-like protein 1 (CYTL1). Cytokine. 2017;96:238–46.CrossRefPubMed
28.
go back to reference Xiang D, Zhang J, Chen Y, Guo Y, Schalow A, Zhang Z, Hu X, Yu H, Zhao M, Zhu S, et al. Expressions and purification of a mature form of recombinant human Chemerin in Escherichia Coli. Protein Expr Purif. 2010;69(2):153–8.CrossRefPubMed Xiang D, Zhang J, Chen Y, Guo Y, Schalow A, Zhang Z, Hu X, Yu H, Zhao M, Zhu S, et al. Expressions and purification of a mature form of recombinant human Chemerin in Escherichia Coli. Protein Expr Purif. 2010;69(2):153–8.CrossRefPubMed
29.
go back to reference Magistrelli G, Gueneau F, Muslmani M, Ravn U, Kosco-Vilbois M, Fischer N. Chemokines derived from soluble fusion proteins expressed in Escherichia Coli are biologically active. Biochem Biophys Res Commun. 2005;334(2):370–5.CrossRefPubMed Magistrelli G, Gueneau F, Muslmani M, Ravn U, Kosco-Vilbois M, Fischer N. Chemokines derived from soluble fusion proteins expressed in Escherichia Coli are biologically active. Biochem Biophys Res Commun. 2005;334(2):370–5.CrossRefPubMed
30.
go back to reference Kim MJ, Park HS, Seo KH, Yang HJ, Kim SK, Choi JH. Complete solubilization and purification of recombinant human growth hormone produced in Escherichia Coli. PLoS One. 2013;8(2):e56168.CrossRefPubMedPubMedCentral Kim MJ, Park HS, Seo KH, Yang HJ, Kim SK, Choi JH. Complete solubilization and purification of recombinant human growth hormone produced in Escherichia Coli. PLoS One. 2013;8(2):e56168.CrossRefPubMedPubMedCentral
31.
go back to reference von Hundelshausen P, Agten SM, Eckardt V, Blanchet X, Schmitt MM, Ippel H, Neideck C, Bidzhekov K, Leberzammer J, Wichapong K, et al. Chemokine interactome mapping enables tailored intervention in acute and chronic inflammation. Sci Transl Med. 2017;9(384):eaah6650. doi:10.1126/scitranslmed.aah6650. von Hundelshausen P, Agten SM, Eckardt V, Blanchet X, Schmitt MM, Ippel H, Neideck C, Bidzhekov K, Leberzammer J, Wichapong K, et al. Chemokine interactome mapping enables tailored intervention in acute and chronic inflammation. Sci Transl Med. 2017;9(384):eaah6650. doi:10.​1126/​scitranslmed.​aah6650.
Metadata
Title
Functional expression of CCL8 and its interaction with chemokine receptor CCR3
Authors
Baosheng Ge
Jiqiang Li
Zhijin Wei
Tingting Sun
Yanzhuo Song
Naseer Ullah Khan
Publication date
01-12-2017
Publisher
BioMed Central
Published in
BMC Immunology / Issue 1/2017
Electronic ISSN: 1471-2172
DOI
https://doi.org/10.1186/s12865-017-0237-5

Other articles of this Issue 1/2017

BMC Immunology 1/2017 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.